Google vs. Death? Really?
By Pete Shanks,
Huffington Post
| 10. 03. 2013
Has Google gone right off the deep end? It's common for techies to be infatuated with transhumanism and other far-out ideas, but "solving death" seems like a real stretch. And yet that's what the megacompany's latest initiative is apparently meant to do.
Perhaps we should have seen this coming. The company did help start 23andMe, the direct-to-consumer genetic testing company run by co-founder Sergei Brin's (now estranged) wife. It also made a failed attempt to launch Google Health, a different data-storing effort. Even more significantly, it contributed to Singularity University, which isn't a university and doesn't have much to do with singularity but gets its name from the idea that "humans and machines will at some point merge, making old age and death meaningless." That's the kind of thinking that passes for radical in Silicon Valley.
Time magazine just published a cover story (mostly behind a pay wall) that is essentially a puff piece about Google. Most of the article focuses on Larry Page's tenure as CEO and the Google X division run by Brin. But the...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026